Skip to main navigation Skip to search Skip to main content

Nanotechnology Assisted Strategies to Tackle COVID and Long-COVID

  • Keshaw R. Aadil
  • , Khushboo Bhange
  • , Gita Mishra
  • , Aresh Sahu
  • , Samiksha Sharma
  • , Neha Pandey
  • , Yogendra Kumar Mishra
  • , Ajeet Kaushik
  • , Raj Kumar
  • Govt. Digvijay Autonomous Post-Graduate College
  • Pt. Jawahar Lal Nehru Memorial Medical College
  • Guru Ghasidas University
  • University of Michigan, Ann Arbor
  • Chhattisgarh Institute of Medical Sciences
  • Kristu Jayanti College (Autonomous)
  • University of Southern Denmark
  • Florida Polytechnic University
  • Chandigarh University

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

In early December 2019, a novel coronavirus, namely SARS-CoV-2, emerged, leading to a series of atypical respiratory illnesses collectively termed COVID-19. This highly transmissible virus swiftly escalated into a global pandemic, profoundly affecting human life worldwide. Developing effective treatments for COVID-19 tackling was challenging due to the limited understanding of the virus, its mechanism of action, and its pathophysiology. This article provide a comprehensive review of SARS-CoV-2, its mechanisms of infection, and its short- and long-term impact on the human body. This report also explores various antiviral drugs, such as ivermectin, lopinavir, favipiravir, remdesivir, hydroxychloroquine, ribavirin, and corticosteroids, and their potential mechanisms of action against COVID-19. Additionally, it delves into nanotechnology-based approaches for COVID-19 management, including the use of nanoparticle-based protective equipment, diagnostic tools, and vaccines, such as protein subunit vaccines, nucleic acid–derived (mRNA and DNA) vaccines, and biomimetic vaccines, along with ongoing clinical trials for various vaccines. The long-term effects of COVID-19, known as long COVID-19, have become a major concern and one of the focus of this report. This review examines its manifestations, including neurological, pulmonary, cardiac, and cutaneous symptoms and explores potential treatment approaches for long COVID-19. Finally, the review summarizes the benefits, risks, and side effects associated with vaccines, highlighting the need for further research, particularly in developing advanced nanocarrier systems for vaccine delivery. The outcomes of this article motivate scientists to developed more precise approaches suitable for personalized COVID-19 pandemic management and related health consequences.

Original languageEnglish
Article number217
JournalBioNanoScience
Volume15
Issue number2
DOIs
StatePublished - Jun 2025
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Drug delivery
  • Long COVID-19
  • Nanotechnology
  • SARS-CoV-2
  • Vaccines

Fingerprint

Dive into the research topics of 'Nanotechnology Assisted Strategies to Tackle COVID and Long-COVID'. Together they form a unique fingerprint.

Cite this